Home
About
Overview
Sharing Data
ORCID
Help
History (23)
Prescription contraception use and adherence by women with substance use disorders.
Mechanisms of targeting CD28 by a signaling monoclonal antibody in acute and chronic allograft rejection.
Molecular Determinants of Epistasis in HIV-1 Protease: Elucidating the Interdependence of L89V and L90M Mutations in Resistance.
Cost and Utility of Microbiological Cultures Early After Intensive Care Unit Admission for Intracerebral Hemorrhage.
Benefits and harms of roflumilast in moderate to severe COPD.
See All 23 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Benefits and harms of roflumilast in moderate to severe COPD.
Yu T, Fain K, Boyd CM, Singh S, Weiss CO, Li T, Varadhan R, Puhan MA. Benefits and harms of roflumilast in moderate to severe COPD. Thorax. 2014 Jul; 69(7):616-22.
View in:
PubMed
subject areas
Aged
Aminopyridines
Benzamides
Cyclopropanes
Female
Humans
Male
Middle Aged
Phosphodiesterase 4 Inhibitors
Placebos
Pulmonary Disease, Chronic Obstructive
Risk Assessment
authors with profiles
Sonal Singh MD, MPH